Log In
Print
BCIQ
Print
Print this Print this
 

Inhaled tobramycin (Vantobra)

  Manage Alerts
Collapse Summary General Information
Company Pari GmbH
DescriptionAerosol formulation of tobramycin
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationPseudomonas
Indication DetailsTreat Pseudomonas aeruginosa infection in patients with cystic fibrosis (CF)
Regulatory Designation

EU - Orphan Drug (Treat Pseudomonas aeruginosa infection in patients with cystic fibrosis (CF));
EU - Standard Review (Treat Pseudomonas aeruginosa infection in patients with cystic fibrosis (CF))

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today